LaVoieHealthScience

Alphabetical Index | Geographical Index | Specialty Index

---

LaVoieHealthScience

20 Park Plaza, Suite 312, Boston, MA 02116

617/374-8800

hello@lavoiehealthscience.com

https://lavoiehealthscience.com
Strategic communications including public relations, investor relations and corporate communications, as well as marketing and digital communications.

Employees: 24. Founded: 2001.

Agency Statement:

(L to R) Sharon Correia, EVP and Chief Strategy Officer; James Heins, Senior Vice President & Managing Director, NY Practice, Lisa DeScenza, VP, Integrated Communications & Head, BD & Marketing; Paul Sagan, VP, IR & Corp. Comms; Donna L. LaVoie, President & CEO; Ella Deych, SVP, Finance and Chief Operations Officer; Sharon Choe, SVP & Head, Investor Outreach & Corporate Access; Douglas Russell, SVP, Client Service & PR/Media; Harriet Ullman, VP, PR & Product Communications

LaVoieHealthScience advances health and science innovations through strategic communications. We offer fully integrated public relations, investor relations, marketing and digital services and are ranked among the Top 30 independent healthcare communications agencies in the United States according to O'Dwyer's 2021 public relations firm rankings. We are certified in healthcare communications compliance and serve commercial and pre-commercial clients both domestically and globally. Through our alliance with Omnicom Public Relations Group, we bring our global clients a broader set of health and science teams offering over 2,000 health experts worldwide. We are committed to serving health and science clients offering domain experience in animal science, CAR-T, rare disease, cell and gene therapy, immuno-oncology, oncology, CNS, neurodegeneration, medtech, medical devices, ophthalmology, precision medicines, RNA, autoimmune diseases, CRISPR, regenerative medicine, and lysosomal diseases. We have been in business for 20 years, have won over 50 public relations and investor relations awards, developed over 325 communications plans, and have doubled the size of the agency since 2017.

Donna L. LaVoie, pres. & CEO; Sharon Correia, exec. VP & chief strategy officer; James Heins, sr. VP & mng. dir., NY practice; Lisa DeScenza, VP, integrated comms. & head, BD & mktg.; Paul Sagan, VP, IR & corp. comms; Ella Deych, sr. VP, finance & COO; Sharon Choe, sr. VP & head, investor outreach & corporate access; Douglas Russell, sr. VP, client service & PR/Media; Harriet Ullman, VP, PR & product comms.

58 Greenpoint Ave., Brooklyn, NY 11222
Sharon Choe
917/945-2068

Clients Include:

AC Immune SA
Biotechnology Innovation Association
Newron Pharmaceuticals SpA
Nuritas
Venthera
Celavie Biosciences
TriSalus Life Sciences
Ocugen
Omega Therapeutics
Outlook Therapeutics
Protalix Biotherapeutics
SIRION Biotech
TFF Pharmaceuticals
TG Therapeutics
Xontogeny LLC

 Printer Friendly